HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Antiga Selected Research

Interleukins

1/2017T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.
5/2011Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematosus.
3/2009Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Antiga Research Topics

Disease

4Inflammation (Inflammations)
04/2015 - 07/2006
4Psoriasis (Pustulosis Palmaris et Plantaris)
05/2011 - 03/2009
4Atopic Dermatitis (Atopic Eczema)
05/2011 - 11/2006
3Dermatitis Herpetiformis (Disease, Duhring's)
06/2021 - 10/2005
3Cutaneous Lupus Erythematosus
04/2019 - 08/2009
2Skin Diseases (Skin Disease)
08/2021 - 10/2014
2Vasculitis (Vasculitides)
04/2017 - 04/2015
2Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
01/2017 - 10/2014
2Pyoderma Gangrenosum
01/2017 - 10/2014
2Dermatomyositis (Dermatopolymyositis)
10/2014 - 12/2010
2Chronic Urticaria
05/2010 - 07/2006
2Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2008 - 05/2006
2Erythema Multiforme
01/2008 - 05/2006
1Neoplasms (Cancer)
08/2021
1Livedo Reticularis
04/2019
1Purpura
04/2019
1Telangiectasis (Telangiectasia)
04/2019
1Antisynthetase syndrome
04/2017
1Acne Vulgaris
04/2015
1Localized Scleroderma (Morphea)
10/2014
1Systemic Scleroderma (Systemic Sclerosis)
10/2014
1Connective Tissue Diseases (Connective Tissue Disease)
10/2014
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
10/2012
1Bullous Pemphigoid (Pemphigoid)
10/2012
1Discoid Lupus Erythematosus
05/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2011
1Urticaria (Hives)
07/2006

Drug/Important Bio-Agent (IBA)

5AutoantibodiesIBA
04/2019 - 07/2006
5CytokinesIBA
10/2014 - 07/2006
3AntibodiesIBA
04/2019 - 08/2009
3InterleukinsIBA
01/2017 - 03/2009
3CD40 Ligand (CD40L)IBA
01/2017 - 05/2006
3Tacrolimus (Prograf)FDA LinkGeneric
04/2011 - 11/2006
2Chemokine ReceptorsIBA
01/2017 - 07/2006
2Interleukin-13IBA
01/2017 - 01/2008
2ChemokinesIBA
10/2014 - 07/2006
2Fas Ligand Protein (Fas Ligand)IBA
10/2014 - 10/2005
2Ointments (Pastes)IBA
04/2011 - 02/2007
2Etanercept (Enbrel)FDA Link
07/2010 - 03/2009
2AcitretinFDA Link
07/2010 - 03/2009
1dupilumabIBA
08/2021
1Glutens (Glutelin)IBA
06/2021
1Immunoglobulin A (IgA)IBA
06/2021
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
04/2019
1anti-dsDNA autoantibodyIBA
04/2019
1Interleukin-4 (Interleukin 4)IBA
01/2017
1Interleukin-5 (Interleukin 5)IBA
01/2017
1Interleukin-15 (Interleukin 15)IBA
01/2017
1InterferonsIBA
01/2017
1Docetaxel (Taxotere)FDA Link
04/2016
1AndrogensIBA
04/2015
1NeuropeptidesIBA
04/2015
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
10/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2011
1Interleukin-10 (Interleukin 10)IBA
05/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2011
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010
1efalizumab (Raptiva)FDA Link
04/2009
1Interleukin-23 (Interleukin 23)IBA
03/2009
1Interleukin-17 (Interleukin 17)IBA
03/2009
1Interleukin-22 (IL-22)IBA
03/2009
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2007
1hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric
11/2006
1IgE Receptors (Fc epsilon RI)IBA
07/2006
1Interleukin-8 (Interleukin 8)IBA
07/2006
1Immunoglobulin E (IgE)IBA
07/2006

Therapy/Procedure

2Therapeutics
06/2021 - 04/2015
1Gluten-Free Diet
06/2009
1Aftercare (After-Treatment)
03/2009